These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 833237)

  • 21. The simultaneous determination of propoxyphene and norpropoxyphene in human biofluids using gas-liquid chromatography.
    Verebely K; Inturrisi CE
    J Chromatogr; 1973 Jan; 75(2):195-205. PubMed ID: 4701539
    [No Abstract]   [Full Text] [Related]  

  • 22. Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry.
    Crews B; Mikel C; Latyshev S; West R; Pesce A
    J Anal Toxicol; 2009 Sep; 33(7):379-83. PubMed ID: 19796508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels.
    Welling PG; Lyons LL; Tse FL; Craig WA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):559-65. PubMed ID: 1277712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma protein binding of d-propoxyphene in normal subjects and anephric patients.
    Giacomini KM; Gibson TP; Levy G
    J Clin Pharmacol; 1978; 18(2-3):106-9. PubMed ID: 624774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of new d-propoxyphene derivatives and the development of a microparticle-based immunoassay for the detection of propoxyphene and norpropoxyphene.
    Wu RS; McNally AJ; Pilcher IA; Salamone SJ; Rashid S
    Bioconjug Chem; 1997; 8(3):385-90. PubMed ID: 9177845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high propoxyphene concentration.
    Eberhardt RD; Cash DK; Oehldrich JR
    J Anal Toxicol; 1984; 8(5):246-7. PubMed ID: 6503231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of dextropropoxyphene and norpropoxyphene in plasma by high-performance liquid chromatography.
    Pettersson KJ; Nilsson LB
    J Chromatogr; 1992 Oct; 581(1):161-4. PubMed ID: 1430002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal decomposition of propoxyphene during GLC analysis.
    Millard BJ; Sheinin EB; Benson WR
    J Pharm Sci; 1980 Oct; 69(10):1177-9. PubMed ID: 7420286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new g.c. procedure, based on nitrosation, for the simultaneous determination of propoxyphene and norpropoxyphene in biological material.
    Serfontein WJ; de Villiers LS
    J Pharm Pharmacol; 1976 Sep; 28(9):718-9. PubMed ID: 10401
    [No Abstract]   [Full Text] [Related]  

  • 32. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.
    Nickander R; Smits SE; Steinberg MI
    J Pharmacol Exp Ther; 1977 Jan; 200(1):245-53. PubMed ID: 13200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.
    Girre C; Hirschhorn M; Bertaux L; Palombo S; Dellatolas F; Ngo R; Moreno M; Fournier PE
    Eur J Clin Pharmacol; 1991; 41(2):147-52. PubMed ID: 1743247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of plasma levels of propoxyphene and norpropoxyphene by combined use of stable isotope labeling and selected ion monitoring.
    Sullivan HR; Emmerson JL; Marshall FK; Wood PG; McMahon RE
    Drug Metab Dispos; 1974; 2(6):526-32. PubMed ID: 4155676
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of dextropropoxyphene and norpropoxyphene in autopsy material.
    Christensen H
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):289-97. PubMed ID: 576558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas chromatographic quantitation of dextropropoxyphene and norpropoxyphene in urine after solid-phase extraction.
    Amalfitano G; Bessard J; Vincent F; Eysseric H; Bessard G
    J Anal Toxicol; 1996; 20(7):547-54. PubMed ID: 8934304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute poisoning with dextropropoxyphene. Clinical symptoms and plasma concentrations.
    Gustafson A; Gustafsson B
    Acta Med Scand; 1976; 200(4):241-8. PubMed ID: 983792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interaction of propoxyphene with ethanol.
    Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL
    Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased absorption of propoxyphene by activated charcoal.
    Glab WN; Corby DG; Decker WJ; Coldiron VR
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):129-38. PubMed ID: 6125599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.